(Q34129991)

31 July 2017

title

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine (English)

1 reference

31 July 2017

0 references

1 reference

2

Robert R Conley

1 reference

31 July 2017

Elaine Weiner

1

1 reference

31 July 2017

M Patricia Ball

3

1 reference

31 July 2017

Stephanie Feldman

4

1 reference

31 July 2017

James M Gold

5

1 reference

31 July 2017

Deanna L Kelly

6

1 reference

31 July 2017

Ikwunga Wonodi

7

1 reference

31 July 2017

Robert P McMahon

8

1 reference

31 July 2017

Robert W Buchanan

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

21 July 2010

1 reference

31 July 2017

published in

Neuropsychopharmacology

1 reference

31 July 2017

volume

35

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

2274-2283

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2010.101

31 July 2017

exact match

0 references

cites work

Intention-to-treat. What is the question?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

The Akt-GSK-3 signaling cascade in the actions of dopamine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Clozapine alone versus clozapine and risperidone with refractory schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Estimating and comparing univariate associations with application to the prediction of adult obesity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Impaired attention, genetics, and the pathophysiology of schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

A rating scale for extrapyramidal side effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Locally Most Powerful Tests for Detecting Treatment Effects When Only a Subset of Patients Can Be Expected to "Respond" to Treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

A rating scale for drug-induced akathisia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Diagnostic criteria and five-year outcome in schizophrenia. A report from the International Pilot Study of schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Structural evaluation of the prefrontal cortex in schizophrenia.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2010.101

Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2010.101

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Short-term and long-term memory in early temporal lobe dysfunction.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Augmentation With a Second Antipsychotic in Patients With Schizophrenia Who Partially Respond to Clozapine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939921

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial

28 October 2018

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study

1 reference

12 December 2020

Subjective response to neuroleptics in schizophrenia

1 reference

12 December 2020

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study

1 reference

12 December 2020

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

12 December 2020

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2010.101

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NPP.2010.101

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference